RUN Gastroenterology
(Die Seite wurde neu angelegt: „{{tp|p=32304737|t=ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic |pdf=|usr=}} {{tp|p=323036…“)
Zum nächsten Versionsunterschied →
Version vom 15. Juni 2020, 13:14 Uhr
32304737 ä. Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic
32303607 2020. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
32363528 ä. Going Viral: Management of IBD in the Era of the COVID-19 Pandemic
32350734 ä. Hernia in the time of COVID-19
32314563 ä. Responding to COVID-19: Perspectives from the Chinese Society of Gastroenterology
32272113 ä. Management of Patients with Crohn?s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting
32360567 ä. Inflammatory bowel disease management during the COVID-19 outbreak: a survey from the European Crohn?s and Colitis Organization (ECCO)
32353371 ä. Is SARS-CoV-2 Also an Enteric Pathogen with Potential Fecal-Oral Transmission: A COVID-19 Virological and Clinical Review
32362732 ä. Joint Guidance from SGEI, ISG and INASL for Gastroenterologists and Gastrointestinal Endoscopists on the Prevention, Care, and Management of Patients With COVID-19
32221526 ä. COVID-19 Outbreak and Inflammatory Bowel Disease Management: A Questionnaire Survey From Realistic Practice
32215548 ä. Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?
32211765 ä. Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience
32330477 ä. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain)
32305331 ä. Inflammatory bowel diseases and COVID-19: the invisible enemy
32298769 ä. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
32283100 ä. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
32283134 ä. Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia
32276846 ä. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time
